BerganKDV Wealth Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the 2nd quarter, Holdings Channel reports. The fund owned 24,756 shares of the healthcare conglomerate’s stock after buying an additional 528 shares during the period. UnitedHealth Group makes up 1.2% of BerganKDV Wealth Management LLC’s investment portfolio, making the stock its 17th largest position. BerganKDV Wealth Management LLC’s holdings in UnitedHealth Group were worth $9,913,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in UNH. Anfield Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $26,000. Lake Point Wealth Management acquired a new stake in UnitedHealth Group in the second quarter valued at approximately $40,000. Harbour Investments Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $41,000. Selective Wealth Management Inc. lifted its position in shares of UnitedHealth Group by 535.3% during the 2nd quarter. Selective Wealth Management Inc. now owns 108 shares of the healthcare conglomerate’s stock valued at $43,000 after buying an additional 91 shares in the last quarter. Finally, Bradley & Co. Private Wealth Management LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth $48,000. Institutional investors and hedge funds own 86.21% of the company’s stock.
In other news, Director Stephen J. Hemsley sold 60,000 shares of the company’s stock in a transaction that occurred on Friday, July 16th. The stock was sold at an average price of $420.62, for a total transaction of $25,237,200.00. Following the completion of the sale, the director now owns 941,560 shares in the company, valued at $396,038,967.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction on Monday, June 21st. The stock was sold at an average price of $398.62, for a total transaction of $1,594,480.00. Following the completion of the sale, the director now owns 154,181 shares of the company’s stock, valued at approximately $61,459,630.22. The disclosure for this sale can be found here. Insiders sold 100,438 shares of company stock worth $41,902,034 in the last three months. 0.55% of the stock is currently owned by corporate insiders.
Shares of NYSE:UNH traded up $7.64 during midday trading on Wednesday, reaching $420.18. 91,772 shares of the company’s stock were exchanged, compared to its average volume of 2,983,495. The firm’s 50 day simple moving average is $416.16 and its two-hundred day simple moving average is $398.29. UnitedHealth Group Incorporated has a fifty-two week low of $289.64 and a fifty-two week high of $431.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.77 and a quick ratio of 0.77. The stock has a market cap of $396.19 billion, a price-to-earnings ratio of 27.25, a P/E/G ratio of 1.62 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, July 14th. The healthcare conglomerate reported $4.70 EPS for the quarter, topping the consensus estimate of $4.43 by $0.27. The firm had revenue of $71.32 billion for the quarter, compared to analyst estimates of $69.51 billion. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period in the prior year, the business posted $7.12 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 18.74 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th will be issued a dividend of $1.45 per share. The ex-dividend date is Friday, September 10th. This represents a $5.80 dividend on an annualized basis and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.36%.
About UnitedHealth Group
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Recommended Story: Why is the conference call important?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.